Bayer stock at EUR 55.07, down 0.92% before Xetra
Published on 11/09/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for Bayer investors
- Bayer operates across Crop Science, Pharmaceuticals and Consumer Health.
- The company's investor-relations agenda focuses on health, nutrition and its 2026 investment case.
- The premarket indication comes ahead of the next Xetra session.
Bayer stock slips before Xetra
The real-time quote of Bayer stock traded at EUR 55.07 on Lang & Schwarz at 08:13 CET on Monday, November 9, 2026, down 0.92 percent from the Xetra close of Friday, November 6, 2026.
The premarket indication points to a weaker starting position after the previous Xetra session. It can still change before regular trading begins, so the opening auction will determine whether the early direction holds.
Bayer's business spans Crop Science, Pharmaceuticals and Consumer Health. The company's Investor Relations materials present health, nutrition and the 2026 investment case as central themes for shareholders.
For investors, the immediate focus is the transition from the premarket indication to the next Xetra session. Trading volume and the broader German market tone will help determine whether the early move develops into a wider session trend.
The DAX provides the broader German market backdrop for Bayer stock.
More news and analyses on Bayer stock cover the company's operating outlook, business segments and market developments.
